News

The latest on managing care, value-based care, insurance markets, payers & providers

Biologics among fastest growers











The U.S. pharmaceutical market was $211 billion in 2003, the first time the market exceeded $200 billion. Roughly $22 billion of that market was biotech products, according to IMS Health. The strongest growth was seen in the generic and biologic sectors. Managed care plans and pharmacy benefit managers can benefit from the strong generic presence in the market, but also face challenges relating to biotech drugs.

Dollar growth in sales

September 2002–September 2003

SOURCE: RETAIL AND PROVIDER PERSPECTIVE, IMS HEALTH, PLYMOUTH MEETING, PA, 2003

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

  • Doug Jones and the ACA, Epic misses a White House meeting, and man caves for man-flu sufferers
  • CVS-Aetna deal may trigger merger mania, Johns Hopkins criticized for lack of asthma prevention, & Columbia sees free-ride future for all of its med students

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.